Wells Fargo & Company Trans Medics Group, Inc. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 169,478 shares of TMDX stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
169,478
Previous 132,756
27.66%
Holding current value
$11.8 Million
Previous $20.8 Million
49.3%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding TMDX
# of Institutions
375Shares Held
31.5MCall Options Held
465KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.64MShares$253 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$184 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$100 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$88.5 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$76.1 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.21B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...